Modified ORS Solution for Severely Malnourished Children
NCT01821586 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 189
Last updated 2016-12-21
Summary
Diarrhoea and malnutrition are the common childhood illnesses responsible for higher deaths in developing counties. Physiologically, malnourished children excrete lower amounts of salts and water in diarrhoeal stools, and they also are unable to handle excessive salts and water load. Some times they are found to be hyponatraemic due to the shift of sodium inside the cells (inefficient Na+ /K+ pump), and fluids containing higher amounts of sodium (such as the standard ORS) may lead to further increase in the intracellular sodium, fluid overload and heart failure. They also have depleted in potassium stores in the body. Recently, the WHO recommended a special ORS formulation, known as ReSoMal, for management of diarrhoea in severely malnourished children that contains a lower amount of sodium (45mmol/L) and higher amount of potassium (40 mmol/L) than the standard WHO-ORS. It is felt that an ORS containing lower sodium and higher potassium concentration may be useful in correcting hypokalemia, and in lowering the risks of excess sodium and /or overhydration, in severely malnourished children with diarrhoea. The safety of ReSoMaL is, however, still in question due to the risk of hyponatraemia, including symptomatic hyponatraemia, especially in the treatment of severe watery diarrhoea due to Vibrio cholerae and ETEC where loss of sodium in the stool exceeds than that is contained in ReSoMal. Thus an ORS solution with modest concentration of sodium (75 mmol/L) and higher concentration of potassium (40 mmol/L) have been suggested for the treatment of diarrhoea in these children. To improve the efficacy of oral rehydration, in terms of reducing the severity of purging and diarrhoea duration, different approaches (changing the substrates/ reducing the sodium and glucose concentration and osmolarity) have been tried with limited success. Benefiber (partially hydrolysed guar gum), a soluble fiber if added to a ORS solution is expected to be fermented in the colon liberating short chain fatty acids (SCFAs). SCFAs stimulate sodium and water absorption from the colon, and they have trophic effect, act as a fuel source for the colonocytes, have antibacterial properties and stimulates the production commensal flora, thereby may enhance recovery from acute diarrhoea in severely malnourished children. The aims of our proposed study are to examine whether an ORS solution with a modest concentration of sodium will prevent the occurrence of hyponatraemia including symptomatic hyponatraemia, and also whether addition of benefiber will improve the efficacy of ORS solution. This will be a randomized, double blind, controlled clinical trial in 186 children with severe malnutrition and watery diarrhoea (62 in each of the three treatment groups) to compare the efficacy of (i) the currently recommended ORS with some modofication(Na+ 75 mmol/L and K40 momol/L and minerals-Zinc, copper and magnesium), (ii) ReSoMal (Na+ 45 mmol/L), (iii) Currently recommended ORS (Na+ 75 mmol/L, K 40 momol/L and added minerals) with added Benefiber (25 grams/L), in the treatment of acute watery diarrhoea in children with severe malnutrition
Conditions
- Malnourished Children With Watery Diarrhoea
Interventions
- OTHER
-
Modified ORS-1
- OTHER
-
Modified ORS-2 (ReSoMal)
- OTHER
-
Modified ORS-3 (Benefibre)
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
collaborator OTHER -
International Centre for Diarrhoeal Disease Research, Bangladesh
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 36 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
Countries
- Bangladesh
Study Locations
More Related Trials
-
Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis
NCT01234883 ·Status: TERMINATED ·Phase: PHASE4
-
Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)
NCT01306578 ·Status: COMPLETED ·Phase: NA
-
Sucrose at Triage for Acute Gastroenteritis Episode in Children
NCT05378776 ·Status: COMPLETED ·Phase: NA
-
Safer Parenteral Nutrition in Pediatric Short Bowel Syndrome to Decrease Liver Damage
NCT01861834 ·Status: APPROVED_FOR_MARKETING
-
Management of Shock in Children With SAM or Severe Underweight and Diarrhea
NCT04750070 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease.
NCT04022941 ·Status: COMPLETED ·Phase: NA
-
Safety, Acceptability, and Feasibility of Enterade®
NCT03782272 ·Status: TERMINATED ·Phase: NA
-
Gastric Emptying During Labor at Term: Non-inferiority Clinical Trial
NCT03280706 ·Status: COMPLETED ·Phase: NA
-
Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) Patients
NCT02780570 ·Status: COMPLETED ·Phase: PHASE2
-
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
NCT03530852 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Time and Resources for Hylenex-facilitated SC Rehydration Versus ORT for Dehydrated Children in the Emergency Department (ED)
NCT01120431 ·Status: WITHDRAWN ·Phase: PHASE4
-
Adrenal Cortical Function and Vitamin A Deficiency in Sepsis
NCT03152474 ·Status: COMPLETED ·Phase: PHASE4
-
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
NCT02682381 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
NCT06842134 ·Status: COMPLETED ·Phase: PHASE1
-
Re-Evaluation of Systemic Early Neuromuscular Blockade and Transthoracic Ultrasound Assessment of the Diaphragm
NCT03132896 ·Status: WITHDRAWN
-
Saline Enema Administration in Meconium Obstruction of Prematurity and Impact on the Resolution, Feeds, Microbiome, and Gut-brain Axis.
NCT06048614 ·Status: RECRUITING ·Phase: NA
-
Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning
NCT06798142 ·Status: ACTIVE_NOT_RECRUITING
-
Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency
NCT00004386 ·Status: TERMINATED ·Phase: PHASE1
-
Interest of Levosimendan in Reducing Weaning Failures of ExtraCorporeal Life Support - ECLS
NCT04158674 ·Status: TERMINATED ·Phase: PHASE3
-
Rectal Ozone as Neuroprotector Post CNS Insult in Children
NCT07153627 ·Status: RECRUITING ·Phase: NA
-
Comparison of Enteral Versus Intravenous Potassium Supplementation
NCT02015962 ·Status: UNKNOWN ·Phase: PHASE4
-
Study With Medical Nutrition Product PTM202 in Pediatric Diarrhea
NCT01814202 ·Status: COMPLETED ·Phase: NA
-
Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency
NCT06497829 ·Status: RECRUITING ·Phase: NA
-
To Study the Effects of Lipid Emulsion on Hemodynamics in Organophosphate Compound Poisoning
NCT03564574 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
NCT00605826 ·Status: COMPLETED ·Phase: NA